Ultravist Injection
Product Images NDC 50419-347

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ultravist (NDC 50419-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 50419-348-21 (south Africa) (F490274b 9be9 44e7 93c3 370cc2a7121a 00)

Ultravist 370 mg/mL solution label from Bayer HealthCare Pharmaceuticals Inc. The label indicates a concentration of 370 mg/mL iopromide, with packaging details for 10 bottles of 200 mL each. Includes usage instructions and storage warnings, with barcode and regulatory information visible.*

FDA Label Image

Ndc 50419-348-20 (mexico) (F490274b 9be9 44e7 93c3 370cc2a7121a 01)

Ultravist 370 mg/mL solution for injection packaging label showing a carton design from Bayer HealthCare Pharmaceuticals Inc. The label includes product name Ultravist 370, concentration 370 mg/mL, volume 200 mL, and manufacturer details in Spanish. The layout has multiple panels with usage, storage, and regulatory information alongside blue color wave graphics.*

FDA Label Image

Ndc 50419-348-13 (F490274b 9be9 44e7 93c3 370cc2a7121a 02)

Ultravist-370 370 mg/mL injectable solution label showing the Bayer HealthCare Pharmaceuticals Inc. branding. The label indicates 10 bottles of 100 mL each, with product details including active ingredient concentration and packaging information. A barcode and regulatory numbers are also visible on the label.*

FDA Label Image

Ndc 50419-348-12 (africa) (F490274b 9be9 44e7 93c3 370cc2a7121a 03)

Ultravist 370 mg/mL injection packaging label from Bayer HealthCare Pharmaceuticals Inc. The label indicates a 10x100 mL carton with 370 mg/mL concentration and 37 g Iopromide per 100 mL. Text includes dosage information and storage instructions to protect from light and X-rays below 30°C. The label features English and Arabic text and Bayer branding with a blue wave design on the bottom.*

FDA Label Image

Ndc 50419-348-11 (F490274b 9be9 44e7 93c3 370cc2a7121a 04)

The image shows a folded carton packaging label for Ultravist 370 mg/mL injectable solution in a 100 mL vial. The label includes text in English and Arabic, listing Ioopromide as the active ingredient. Branding includes the Ultravist name and Bayer logo. The label specifies the volume as 100 mL and provides product and manufacturer details.*

FDA Label Image

Ndc 50419-348-10 (F490274b 9be9 44e7 93c3 370cc2a7121a 05)

Packaging label for Ultravist 370 mg/mL Iopromide injectable solution. The label indicates a 100 mL vial of 370 mg/mL strength. Bayer HealthCare Pharmaceuticals Inc. is the labeler. The label includes dosage form, strength, barcode, storage instructions, and manufacturer details in Spanish, indicating it is for single 100 mL vials for intravenous use.*

FDA Label Image

Ndc 50419-348-05 (middle East) (F490274b 9be9 44e7 93c3 370cc2a7121a 06)

Ultravist 370 mg/mL injection carton label from Bayer HealthCare Pharmaceuticals Inc. The label indicates it contains iopromide 0.769 g per mL equivalent to 370 mg/mL, with a package size of 10 bottles, each 50 mL. The product is protected from light and secondary X-rays and stored below 30°C. This specific packaging is labeled for the Middle East region.*

FDA Label Image

Ndc 50419-347-20 (mexico) (F490274b 9be9 44e7 93c3 370cc2a7121a 07)

Packaging label for Ultravist 300, a 300 mg/mL injectable solution. The label is for a 200 mL vial and includes product information in Spanish. The labeler is Bayer HealthCare Pharmaceuticals Inc. The design features the Ultravist 300 name prominently along with volume and concentration details, a blue wave graphic, and regulatory information including barcode and manufacturing details.*

FDA Label Image

Ndc50419-347-05 (algeria) (F490274b 9be9 44e7 93c3 370cc2a7121a 08)

Packaging label for Ultravist 300 mg/mL injectable solution, presented in 50 mL unit vials. The label shows the product name Ultravist 300 with iodine content specified, directions in multiple languages including French and Arabic, and the Bayer HealthCare Pharmaceuticals Inc. logo. The design features a blue wave graphic and clear dosage information, indicating a sterile solution for injection or perfusion.*

FDA Label Image

240mgi/50ml (Image 01)

The Ultravist injection vial label displays the proprietary name Ultravist with a concentration of 240 mg/mL. It indicates the solution is sterile and intended for injection only. The label includes usage instructions, cautions, and storage details. Bayer HealthCare Pharmaceuticals Inc. is identified as the labeler. The vial volume is 50 mL as shown on the label.*

FDA Label Image

300mgi/50ml (Image 02)

Ultravist 300 mg/mL sterile solution injection label showing a 50 mL single-dose container. The active ingredient is iopromide. Label indicates 'Rx only' and instructions to discard unused portion. The labeler is Bayer HealthCare Pharmaceuticals Inc. The label includes warnings, storage instructions, and a barcode.*

FDA Label Image

370mgi/50ml (Image 03)

Ultravist 370 mg/mL injection label featuring the Bayer logo. The label indicates a 10 x 50 mL single-dose container package. It includes cautionary text such as 'NOT FOR INTRATHECAL USE,' ingredients, storage instructions, and manufacturer information for Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

Structure (Vial Image 01)

Chemical structure of the active ingredient in Ultravist. The diagram shows a molecular formula with iodine atoms, hydroxyl groups, methyl groups, and amide linkages typical of iodinated contrast agents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.